Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Huang TT et al. - Molecularly targeted therapies are transforming the care of patients with malignant gliomas, including glioblastoma, the most common malignant primary brain tumor of adults. With an arsenal of small molecule inhibitors and antibodies that target key components of the signal transduction machinery that are commonly activated in gliomas, neuro-oncologists and neurosurgeons are poised to transform the care of these patients.

Related Articles

Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy
Arthritis Care and Research, 11/05/09    Relevance Score: 68%

Acute renal failure in septic patients: Epidemiology, diagnosis and therapy
Intensivmedizin und Notfallmedizin, 11/06/09    Relevance Score: 67%

Beta 1 integrin targeting to enhance radiation therapy
International Journal of Radiation Biology, 11/05/09    Relevance Score: 67%

Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
Molecular Cancer Research, 10/20/09    Relevance Score: 67%

Targeted radionuclide therapy in head and neck cancer
Head & Neck, 10/15/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address